Recommendations for clinical practice and research needs directed at reducing morbidity and mortality in peritoneal dialysis.
These presentations highlighted some of the current research needs in peritoneal dialysis. They are not meant to eclipse other important issues, such as adequacy and nutrition. These needs have become apparent as the therapy has evolved and progressed. They in fact are a testament to the increasing acceptance, use, and development of the therapy and suggest that there is potential for even further advancement for the therapy of peritoneal dialysis in the future.
Burkart
J M
JM
Department of Nephrology, Bowman Gray School of Medicine, Winston Salem, North Carolina 27157-1053, USA.
D001424:Bacterial Infections / Q000209:etiology / Q000517:prevention & control; D002404:Catheterization / Q000009:adverse effects / Q000295:instrumentation; D002648:Child; D002664:Child Nutritional Physiological Phenomena; D048909:Diabetes Complications; D005544:Forecasting; D006128:Growth / Q000502:physiology; D006130:Growth Disorders / Q000209:etiology / Q000517:prevention & control; D006331:Heart Diseases / Q000209:etiology / Q000517:prevention & control; D019382:Human Growth Hormone / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007676:Kidney Failure, Chronic / Q000628:therapy; D009747:Nutritional Physiological Phenomena; D010530:Peritoneal Dialysis / Q000009:adverse effects* / Q000379:methods / Q000401:mortality / Q000639:trends; D010537:Peritoneum / Q000502:physiology; D017410:Practice Guidelines as Topic; D006435:Renal Dialysis; D012106:Research; D012307:Risk Factors
D019382:Human Growth Hormone